CSIMarket
 

Healthcare Sector

Biotechnology & Pharmaceuticals Industry Profitability  


 

List of most profitable companies in Biotechnology & Pharmaceuticals Industry over the past 12 months


Company 12 Months Ending from the most recent quarter Net Income In millions $ Net Income Margin Gross Profit Margin ROE
Gilead Sciences Inc 1 Q $ 5,965.00 20.76% 78.29% 31.85%
Amgen Inc 4 Q $ 4,090.00 12.24% 61.53% 67.18%
Inhibrx Biosciences Inc 1 Q $ 1,722.97 - - 1101.19%
Exelixis Inc 1 Q $ 1,481.63 64.45% 96.78% 67.57%
Biogen Inc 1 Q $ 1,479.30 15.07% 75.58% 8.97%
Biontech Se 4 Q $ 1,041.94 24.36% 84.29% 4.6%
Halozyme Therapeutics Inc 1 Q $ 485.36 44.76% 83.45% 122.24%
Novavax inc 1 Q $ 478.70 38.14% 87.44% -
Neurocrine Biosciences Inc 1 Q $ 305.80 12.68% 98.52% 11.81%
Adma Biologics Inc 1 Q $ 240.11 46.94% 54.06% 84.06%
Bluebird Bio Inc 1 Q $ 139.44 - 27.12% -
Krystal Biotech Inc 1 Q $ 123.96 37.18% - 13.56%
Bio techne Corp 1 Q $ 110.51 9.07% 65.44% 5.32%
Qiagen N v 4 Q $ 83.59 4.36% 50.4% 2.34%
Gamida Cell Ltd 1 Q $ 79.38 - - -
Engene Holdings Inc 4 Q $ 69.05 - - 27.73%
Outlook Therapeutics Inc 1 Q $ 21.12 - - -
Pharmacyte Biotech Inc 4 Q $ 17.97 - - 45.2%
X4 Pharmaceuticals Inc 1 Q $ 14.60 46.54% 82.42% 29.32%
Entera Bio Ltd 1 Q $ 9.73 - - 90.98%
Biomx Inc 1 Q $ 8.06 - - 28.29%
Precision Biosciences Inc 4 Q $ 7.17 10.43% - 12.29%
Scinai Immunotherapeutics Ltd 4 Q $ 6.50 - - -
Champions Oncology Inc 4 Q $ 6.43 10.97% 51.58% 656.65%
Monte Rosa Therapeutics Inc 1 Q $ 6.15 3.86% - 2.65%
Tracon Pharmaceuticals Inc 2 Q $ 5.20 46.68% - -
Black Diamond Therapeutics Inc 1 Q $ 5.09 - - 4.7%
Protalix Biotherapeutics inc 1 Q $ 3.91 6.54% 49.97% 10.46%
Vericel Corporation 1 Q $ 2.98 1.25% 72.54% 1.09%
Futuretech Ii Acquisition Corp 3 Q $ 0.57 - - -
Alvotech 4 Q $ 0.00 - - -
Exozymes Inc 4 Q $ 0.00 - - -
Fennec Pharmaceuticals Inc 1 Q $ 0.00 - - -
Liminatus Pharma Inc 1 Q $ 0.00 - - -
Silexion Therapeutics Corp 1 Q $ 0.00 - - -
Vivosim Labs Inc 1 Q $ 0.00 - - -
Green Planet Bioengineering Co Ltd 1 Q $ -0.04 - - -
Qrons Inc 4 Q $ -0.06 - - -
Enzon Pharmaceuticals inc 1 Q $ -0.07 -3.83% - -2.45%
Agentix Corp 4 Q $ -0.39 - - -
Armata Pharmaceuticals Inc 1 Q $ -0.43 -9.41% - -
Mosaic Immunoengineering Inc 1 Q $ -0.81 - - -
10x Capital Venture Acquisition Corp Iii 3 Q $ -1.25 - - -
Tc Biopharm holdings Plc 1 Q $ -1.39 -36.15% - -149.66%
Ladrx Corporation 4 Q $ -1.59 - - -
Peak Bio Inc 3 Q $ -3.32 - - -
Titan Pharmaceuticals Inc 1 Q $ -4.21 - - -145.87%
Zeo Scientifix Inc 1 Q $ -4.90 -107.13% 81.46% -
Atlantic Coastal Acquisition Corp Ii 1 Q $ -5.61 - - -
Fresh Tracks Therapeutics Inc 4 Q $ -5.69 -82.01% - -58.8%
Dyadic International Inc 1 Q $ -5.83 -163.94% 66.88% -233.69%
Creative Medical Technology Holdings Inc 1 Q $ -6.09 -5926.81% 46.73% -85.26%
Tradeup Acquisition Corp 1 Q $ -6.96 - - -107.91%
Channel Therapeutics Corporation 1 Q $ -7.36 - - -
Redwoods Acquisition Corp 1 Q $ -8.26 - - -1906.53%
Biocardia Inc 1 Q $ -8.39 -633.28% - -30792.66%
Innate Pharma Sa 4 Q $ -8.48 -12.28% - -14.59%
Mink Therapeutics Inc 1 Q $ -9.74 - - -
Coeptis Therapeutics Holdings Inc 1 Q $ -9.87 - - -246.71%
Genenta Science S p a 4 Q $ -9.98 - - -71.32%
Phoenix Biotech Acquisition Corp 1 Q $ -10.04 - - -
Tevogen Bio Holdings Inc 4 Q $ -10.27 - - -
Brainstorm Cell Therapeutics inc 1 Q $ -11.09 - - -
Finch Therapeutics Group Inc 2 Q $ -12.58 -2048.05% - -61.37%
Palisade Bio Inc 1 Q $ -13.14 - - -178.91%
Cyclo Therapeutics Inc 3 Q $ -13.26 -1523.26% 85.49% -
Compugen Ltd 4 Q $ -14.23 -51.07% 71.54% -25.92%
Mymetics Corporation 3 Q $ -14.31 -1164.71% - -
Quince Therapeutics Inc 1 Q $ -15.09 - - -42.91%
Atara Biotherapeutics Inc 1 Q $ -15.64 -5.16% - -
Zivo Bioscience Inc 1 Q $ -15.99 -25240.08% 38.05% -
Enzo Biochem Inc 3 Q $ -16.07 -52.54% 45.58% -24.56%
Windtree Therapeutics Inc 1 Q $ -16.13 -2206.57% - -228.88%
Lineage Cell Therapeutics Inc 1 Q $ -16.17 -169.16% 97.15% -22.58%
Intensity Therapeutics Inc 1 Q $ -16.43 - - -361.58%
Xtant Medical Holdings Inc 4 Q $ -16.45 -14.03% 58.2% -36.28%
Aim Immunotech Inc 4 Q $ -17.32 -10188.24% 81.76% -553.44%
Artiva Biotherapeutics Inc 1 Q $ -20.31 - - -22.24%
Pluri Inc 1 Q $ -20.87 -2068.48% 51.34% -
Aptose Biosciences Inc 1 Q $ -21.33 - - -
Cardiol Therapeutics inc 4 Q $ -21.55 - - -99.58%
Immunocore Holdings Plc 1 Q $ -21.63 -6.48% 99.01% -5.86%
Century Therapeutics inc 1 Q $ -21.94 -19.1% - -10.71%
Evaxion Biotech A 4 Q $ -22.13 -30308.22% - -
Calidi Biotherapeutics Inc 4 Q $ -22.21 - - -
Repligen Corp 1 Q $ -22.98 -3.53% 44.37% -1.15%
Kiromic Biopharma Inc 4 Q $ -26.90 - - -
Cel sci Corporation 4 Q $ -27.28 - - -232.43%
In8bio Inc 1 Q $ -27.43 - - -216.95%
Denali Therapeutics Inc 1 Q $ -31.24 -28.22% - -2.47%
Miromatrix Medical inc 3 Q $ -32.05 -2695.74% 57.95% -140.89%
Eloxx Pharmaceuticals Inc 3 Q $ -32.10 - - -
Genfit S a 4 Q $ -32.36 -75.69% - -42.52%
Cognition Therapeutics inc 1 Q $ -33.30 - - -194.42%
Sab Biotherapeutics Inc 1 Q $ -34.28 -58.38% - -105.14%
Inhibikase Therapeutics Inc 1 Q $ -36.55 -59123.53% - -78.96%
Candel Therapeutics Inc 1 Q $ -39.58 -127667.74% - -136.74%
Elutia Inc 1 Q $ -39.89 -171.04% 44.26% -
Inmune Bio Inc 1 Q $ -40.80 -11459.55% - -119.35%
Aceragen Inc 1 Q $ -41.05 - - -215.27%
Ikena Oncology Inc 1 Q $ -41.71 -137.27% - -32%
Curis Inc 1 Q $ -42.13 -376.08% - -
Protara Therapeutics Inc 1 Q $ -44.60 - - -42.68%
Anavex Life Sciences Corp 1 Q $ -47.14 -1081.19% -106.82% -40.93%
Lenz Therapeutics Inc 1 Q $ -47.74 - - -23.74%
Elevation Oncology inc 1 Q $ -47.99 - - -74.68%
Axcella Health Inc 2 Q $ -48.23 - - -
Cardiff Oncology Inc 1 Q $ -48.85 -1831.11% -12.71% -76.45%
Aligos Therapeutics Inc 1 Q $ -53.26 -1628.75% - -104.02%
Biocryst Pharmaceuticals Inc 1 Q $ -53.47 -10.62% 96.91% -
Senti Biosciences Inc 1 Q $ -54.79 -1063.7% - -177.25%
Compass Therapeutics Inc 1 Q $ -55.22 - - -42.48%
Ocugen Inc 1 Q $ -57.44 -1270.15% - -222.83%
Vaxart Inc 1 Q $ -58.12 -122.63% - -91.89%
Allovir Inc 4 Q $ -58.77 - - -49.47%
Poseida Therapeutics Inc 3 Q $ -60.76 -40.28% - -72.26%
Bioatla Inc 1 Q $ -61.88 - - -357.92%
Molecular Partners Ag 4 Q $ -61.98 -880.7% - -35.13%
Zura Bio Limited 1 Q $ -62.10 - - -41.35%
Acorda Therapeutics Inc 1 Q $ -62.49 -62.53% 86.6% -1387.54%
Turnstone Biologics Corp 1 Q $ -63.01 - - -162.8%
Passage Bio Inc 1 Q $ -63.46 - - -93.59%
Atyr Pharma Inc 4 Q $ -64.02 - - -85.17%
Tectonic Therapeutic Inc 1 Q $ -67.08 - - -35.37%
Sqz Biotechnologies Company 3 Q $ -69.27 -331.93% - -223.95%
Achilles Therapeutics Plc 4 Q $ -69.67 - - -48.93%
Adaptimmune Therapeutics Plc 1 Q $ -69.90 -38.52% 97.74% -185.54%
Nkgen Biotech Inc 3 Q $ -72.69 - - -
Orchard Therapeutics Plc 3 Q $ -72.92 -333.9% 69.17% -74.94%
Omega Therapeutics Inc 3 Q $ -73.09 -903.04% - -213.14%
Athira Pharma Inc 1 Q $ -73.11 - - -118.64%
Scilex Holding Company 1 Q $ -74.51 -146.93% 71.93% -
Eiger Biopharmaceuticals Inc 4 Q $ -74.96 -475.26% 99.85% -869.84%
Humacyte Inc 1 Q $ -77.67 -402.37% 99.24% -
Metagenomi Inc 1 Q $ -77.95 -172.21% - -32.05%
Instil Bio Inc 1 Q $ -78.03 -8023.79% - -45.52%
Jasper Therapeutics Inc 1 Q $ -78.78 - - -109.45%
Sangamo Therapeutics Inc 1 Q $ -79.45 -124.61% - -351.16%
Surrozen Inc 1 Q $ -81.70 - - -
Tourmaline Bio Inc 1 Q $ -82.87 - - -26.75%
Vigil Neuroscience Inc 4 Q $ -84.26 - - -96.5%
Voyager Therapeutics Inc 1 Q $ -84.69 -126.49% - -27.36%
Aura Biosciences Inc 4 Q $ -86.92 - - -47.83%
Mesoblast Ltd 2 Q $ -87.96 -1490.27% - -18.31%
Taysha Gene Therapies Inc 4 Q $ -89.30 -1071.62% - -110.57%
Surface Oncology Inc 2 Q $ -92.51 -297.82% - -111.71%
Icosavax Inc 3 Q $ -96.71 -16617.18% - -43.06%
C4 Therapeutics Inc 1 Q $ -103.28 -259.6% - -45.86%
Fusion Pharmaceuticals Inc 1 Q $ -104.28 -11534.96% - -48.74%
Tarsus Pharmaceuticals Inc 1 Q $ -104.94 -44.91% 92.99% -39.72%
Cg Oncology Inc 1 Q $ -105.56 -15945.47% - -16.71%
Lexeo Therapeutics Inc 1 Q $ -109.31 - - -85.86%
Tenaya Therapeutics Inc 4 Q $ -111.13 - - -89.33%
Valneva Se 4 Q $ -113.60 -65.99% 34.37% -79.09%
Acumen Pharmaceuticals Inc 1 Q $ -116.25 - - -58.24%
Dbv Technologies S a 1 Q $ -117.98 -2685.68% - -190.56%
Point Of Care Nano technology Inc 1 Q $ -118.40 - - -
Vor Biopharma Inc 1 Q $ -118.60 - - -142.13%
Alector Inc 1 Q $ -123.44 -139.74% - -100.58%
Cabaletta Bio Inc 1 Q $ -126.76 - - -78.29%
Iteos Therapeutics Inc 1 Q $ -130.81 -28.8% - -21.36%
Coherus Biosciences inc 1 Q $ -130.94 -66.3% 56.65% -
Tscan Therapeutics Inc 1 Q $ -131.48 -2974.08% - -56.22%
Ambrx Biopharma Inc 3 Q $ -134.11 -1559.09% - -67.63%
Solid Biosciences Inc 1 Q $ -139.68 -944.71% - -70.55%
Cidara Therapeutics Inc 1 Q $ -141.00 -216.74% - -102.26%
Adaptive Biotechnologies Corporation 1 Q $ -141.89 -74.87% 62.53% -66.17%
Invivyd Inc 1 Q $ -142.72 -389% - -165.23%
Kyverna Therapeutics Inc 1 Q $ -145.42 - - -51.62%
Hillevax Inc 4 Q $ -147.27 - - -75.27%
Caribou Biosciences Inc 1 Q $ -147.86 -1490.84% - -55.7%
Adverum Biotechnologies Inc 1 Q $ -153.16 -9554.52% - -149.69%
Greenlight Biosciences Holdings Pbc 1 Q $ -157.32 -1521% - -374.26%
Regenxbio Inc 1 Q $ -157.69 -100.62% 78.12% -53.29%
Arcellx Inc 1 Q $ -162.42 -211.46% - -35.27%
Tcr2 Therapeutics Inc 1 Q $ -163.10 - - -97.81%
Prokidney Corp 1 Q $ -165.95 - - -
Nanostring Technologies Inc 3 Q $ -166.43 -102.44% 35.72% -
Meiragtx Holdings Plc 1 Q $ -167.33 -484.9% - -241.89%
Fate Therapeutics Inc 1 Q $ -175.88 -1318.93% - -51.49%
4d Molecular Therapeutics Inc 1 Q $ -176.44 -767126.09% - -33.27%
Cullinan Therapeutics Inc 1 Q $ -178.74 - - -29.47%
Kodiak Sciences Inc 1 Q $ -190.63 - - -115.71%
Twist Bioscience Corporation 1 Q $ -191.15 -54.98% 46.7% -41.11%
Agenus Inc 1 Q $ -195.19 -196.12% 99.48% -
Gritstone Bio Inc 2 Q $ -201.00 -1375.84% - -496.33%
Apogee Therapeutics Inc 1 Q $ -205.39 - - -
Sana Biotechnology Inc 1 Q $ -208.67 - - -76.46%
Cargo Therapeutics Inc 1 Q $ -216.19 - - -58.44%
Opthea Limited 2 Q $ -220.24 -176665.73% - -
Autolus Therapeutics Plc 1 Q $ -238.13 -143453.61% - -52.82%
Kymera Therapeutics Inc 1 Q $ -240.88 -409.07% - -30.11%
Sutro Biopharma Inc 1 Q $ -245.22 -369.11% - -347.59%
Replimune Group Inc 1 Q $ -247.30 - - -57.98%
Editas Medicine Inc 1 Q $ -251.23 -701.04% - -166.29%
Allogene Therapeutics Inc 1 Q $ -252.32 -102155.06% - -56.5%
Neumora Therapeutics Inc 1 Q $ -258.06 - - -84.79%
Scholar Rock Holding Corp 1 Q $ -264.16 -558.47% - -118.22%
Sorrento Therapeutics Inc 2 Q $ -324.52 -636.01% 95.53% -
Relay Therapeutics Inc 1 Q $ -333.39 -47969.21% - -44.16%
Springworks Therapeutics Inc 1 Q $ -348.02 - - -70.03%
Iovance Biotherapeutics inc 1 Q $ -375.36 -176.49% 21.72% -49.71%
Beam Therapeutics Inc 4 Q $ -376.74 -593.13% - -45.77%
Crispr Therapeutics Ag 1 Q $ -385.66 -1023.64% - -20.08%
Immunitybio inc 1 Q $ -409.18 -1310.55% 99.81% -
Immunovant Inc 1 Q $ -413.84 - - -80.6%
Ginkgo Bioworks Holdings Inc 1 Q $ -472.08 -198.84% 80.41% -63.06%
Prime Medicine Inc 1 Q $ -495.41 - - -306.68%
Vaxcyte Inc 1 Q $ -509.63 - - -17.12%
Recursion Pharmaceuticals Inc 1 Q $ -574.78 -961.32% 6.5% -74.7%
Vir Biotechnology Inc 1 Q $ -577.65 -2769.04% 96.23% -47.46%
Revolution Medicines Inc 4 Q $ -600.09 -2033.52% - -33.45%
Seagen Inc 3 Q $ -750.23 -32.61% 75.4% -28.06%
Moderna Inc 1 Q $ -3,357.00 -105.67% 54.11% -30.1%
Profitability
Biotechnology & Pharmaceuticals Industry
Gross margin improved to 72.2 % in 1. Quarter 2025 from 50.29 % in previous quarter, now Ranking #9 and ranking within sector #2.


More on Biotechnology & Pharmaceuticals Industry Profitability

Biotechnology & Pharmaceuticals Industry achieved cash flow margin of 2.5 %

More on Biotechnology & Pharmaceuticals Industry Cash flow
More on Biotechnology & Pharmaceuticals Industry ROE

All numbers are for TTM (Trailing twelve months, or last 4 quarters), MRQ stands for the most recent quarter reported and the period from where the past 12 months are included. The list includes publicly traded companies




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com